Navigating Novel Treatments in Pediatric Hematopoietic Stem Cell Transplantation and Cellular Therapies for Advance Practice Providers - On Demand

Sunday, January 1, 2023, 7:50 AM - Friday, June 30, 2023, 5:40 PM

Hematopoietic stem cell transplant (HSCT) and cellular therapy is a hyper-specialized field within the already specialized pediatric oncology world. This necessitates providers to stay current on the rapidly evolving science behind the care of these complex patients.

This on demand program, consisting of both videos and PDF's of the speakers' presentations, focuses on topics curated for advanced practice providers, including:

• advances in GVHD therapies;
• unique disease processes that are being transplanted more often in the current era;
• diagnostic findings of HSCT complications; and
• new clinical trials that our patients are undergoing including JSP for SCID, TCR modified T-cell therapy for sarcoma patients and expanded cord blood transplant for multiply relapsed leukemia.

Target Audience

The target audience for this on demand includes advanced practice providers who will be caring primarily or be involved in the care of pediatric hemopoietic stem cell transplant patients.

We are pleased to offer complimentary registration for residents, fellows, APP students, and nursing students to attend this course. Please see details below.

On Demand Access

Select the 'Register' tab at the top of this page to purchase this program. Once you have successfully registered, access to the course materials will be available under the 'Course Content' tab.

1. Discuss the role of allogeneic hematopoietic stem transplantation in the treatment of both malignant and non-malignant diseases
2. Identify the how and why hematopoietic stem cell transplant conditioning regimens are selected
3. Describe the pathophysiology and clinical management of common hematopoietic stem cell transplant complications and toxicities
4. Gain knowledge of the new advancements in care of pediatric hematopoietic stem cell transplant patients, including new types of transplants and other alternatives such as gene therapy
5. Summarize the mechanism of acute and chronic GVHD including prophylactic strategies, treatment (including new research based therapies) and supportive care

On Demand Fees

• Physicians (MDs, PhDs and DOs): $100
• Advanced Practice Providers: $75
• Nursing and Other Healthcare Professionals: $50 
• Residents, Fellows, APP Students, and Nursing Students*: complimentary; please see below for details 
• Industry Professionals: $175 

Discounts/Promotions

• *Residents, Fellows, APP Students, and Nursing Students: please email [email protected] to receive a promotion code for complimentary registration.
• A registration discount is available for MSK Alumni, and MSK Cancer Alliance to attend a MSK CME course. If you are a member of one of these groups, contact [email protected] for details.
• Registration is complimentary for all MSK employees; however, you must complete registration through the 'Register' tab above in order to attend this course. If you are registered for this course and are unable to attend, please notify [email protected].

Please note that after your payment has been processed, no further promotional discounts or adjustments will be made to your registration.

Registration for this MSK CME On Demand is non-refundable 

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this enduring material for a maximum of 8.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Recorded/Review Date: November 2, 2022; Original Release Date: January 1, 2023; Termination Date: June 30, 2023 

Course Director

Kimberly Dachisen, MSN, FNP-BC, CPHON

 

Physician Sponsor

Jaap-Jan Boelens, MD, PhD
Chief, Pediatric Stem Cell Transplantation and Cellular Therapies Service
Richard J. O’Reilly Chair in Honor of Kevin Zoltan Merszei

 

Planning Committee

Jennifer Allen, NP

Linda D'Andrea, MSN, PPCNP-BC

Joanne Torok-Castanza, MSN

 

Invited Patient Speaker

Samantha Eisenstein Watson

 

Invited Course Faculty 

Christen Ebens, MD
Assistant Professor
University of Minnesota Masonic Children’s Hospital

Katiana Garagozlo, MD
Clinical Fellow
NewYork-Presbyterian/Weill Cornell Medical Center

Sonata Jodele, MD
Research Professor
Cincinnati Children’s Hospital Medical Center

Parinda Mehta, MD
Professor 
Cincinnati Children’s Hospital Medical Center

Susan Prockop, MD
Program Director for Clinical and Translational Research;
Attending Physician
Boston Children’s Hospital

 

MSK Course Faculty 

Gerald Behr, MD
Associate Attending Radiologist

Sandra D’Angelo, MD
Associate Attending

Gloria Contrares-Yametti, MD
Clinical Fellow

Andrew Harris, MD
Associate Attending

Alina Markova, MD
Assistant Attending

Morgan Mastin, PharmD
Assistant Attending

Joseph Oved, MD
Assistant Professor

Karen Queliza, MD
Assistant Attending

Andromachi Scaradavou, MD
Associate Attending

 

Relevant Financial Relationships

 

Mitigation of Relevant Financial Relationships

Memorial Sloan Kettering Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible companies (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.